Patients Stopping Weight-Loss Injections Regain Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

A recent study reveals that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy can put back on lost weight at a significantly accelerated pace than those who stop conventional lifestyle plans.

Research printed in a major health publication demonstrates that while obese individuals frequently drop about a fifth of their total mass while on the medication, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"People purchasing these medications need to be aware of the risk of quick rebound weight gain when the medication ends," cautioned researcher Dr. Susan Jebb.

This pace of regain implies a return to original weight in about 18 months.

Analyzing Treatments

The research, which examined dozens of studies involving over 9,000 of patients, compared the results of these new drugs with other pills.

Scientists emphasize that people who shed pounds through lifestyle changes alone usually experience a more gradual creep back—perhaps 100 grams monthly—once they finish.

The Reason for the Fast Rebound

Nutrition scientists suggest the mechanism of the drugs explains the heightened weight return.

These medications mimic a body's own chemical called GLP-1, which helps regulate feelings of fullness.

"Artificially providing the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this GLP-1 'fix' leads to hunger is unsuppressed, making overeating a significant risk."

An Ongoing Disease?

Medical guidelines recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

A number of clinicians contend that, due to the likelihood of relapse, the therapy should be considered life-long.

This view is supported by pharmaceutical companies, who say that the findings "emphasize the long-term character of excess weight," similar to managing diseases like hypertension.

User Accounts

Users who have discontinued the jabs describe a intense return of appetite.

"It was like a switch that goes on and I was suddenly starving," said an individual.

The struggle is exacerbated if individuals have not adopted permanent dietary or behavioural changes during therapy.

Widespread Use

Recent estimates indicate that millions of adults in the UK have used weight-loss jabs in the past year, with desire remaining high.

• Use is higher among women than men.
• The 40s and 50s age group shows the highest usage rates.
• Many obtain the medications through private prescriptions rather than public health services.

Finally, researchers stress that while the jabs are potent tools for weight loss, they are not a magic cure and long-term success likely depends on ongoing behavioural management.